PT1326617E - Utilização de 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2-pentafluoroetil)estra-4,9-dien-3-ona para a preparação de um medicamento para o tratamento de cancro da mama, do ovário, do endométrico, mieloma e meningioma - Google Patents

Utilização de 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2-pentafluoroetil)estra-4,9-dien-3-ona para a preparação de um medicamento para o tratamento de cancro da mama, do ovário, do endométrico, mieloma e meningioma Download PDF

Info

Publication number
PT1326617E
PT1326617E PT01987669T PT01987669T PT1326617E PT 1326617 E PT1326617 E PT 1326617E PT 01987669 T PT01987669 T PT 01987669T PT 01987669 T PT01987669 T PT 01987669T PT 1326617 E PT1326617 E PT 1326617E
Authority
PT
Portugal
Prior art keywords
antiprogestin
tumor
treatment
cell
breast cancer
Prior art date
Application number
PT01987669T
Other languages
English (en)
Portuguese (pt)
Inventor
Rosemarie Lichtner
Martin Schneider
Jens Hoffmann
Gerd Siemeister
Ulrike Fuhrmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT1326617E publication Critical patent/PT1326617E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT01987669T 2000-10-18 2001-10-17 Utilização de 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2-pentafluoroetil)estra-4,9-dien-3-ona para a preparação de um medicamento para o tratamento de cancro da mama, do ovário, do endométrico, mieloma e meningioma PT1326617E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24099100P 2000-10-18 2000-10-18
EP00250342 2000-10-18

Publications (1)

Publication Number Publication Date
PT1326617E true PT1326617E (pt) 2006-12-29

Family

ID=26072952

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01987669T PT1326617E (pt) 2000-10-18 2001-10-17 Utilização de 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2-pentafluoroetil)estra-4,9-dien-3-ona para a preparação de um medicamento para o tratamento de cancro da mama, do ovário, do endométrico, mieloma e meningioma

Country Status (29)

Country Link
EP (1) EP1326617B9 (uk)
JP (1) JP2004511523A (uk)
KR (1) KR100668024B1 (uk)
CN (1) CN1209111C (uk)
AT (1) ATE334683T1 (uk)
AU (2) AU2361902A (uk)
BG (1) BG107744A (uk)
BR (1) BR0114696A (uk)
CA (1) CA2423020C (uk)
CY (1) CY1105745T1 (uk)
CZ (1) CZ299823B6 (uk)
DE (1) DE60121980T2 (uk)
DK (1) DK1326617T3 (uk)
EA (1) EA010593B1 (uk)
EE (1) EE200300157A (uk)
ES (1) ES2269492T3 (uk)
HK (1) HK1062273A1 (uk)
HR (1) HRP20030388A2 (uk)
HU (1) HUP0301433A3 (uk)
IL (2) IL154976A0 (uk)
MX (1) MXPA03002955A (uk)
NO (1) NO20031741L (uk)
NZ (1) NZ538347A (uk)
PL (1) PL360157A1 (uk)
PT (1) PT1326617E (uk)
SI (1) SI1326617T1 (uk)
SK (1) SK4702003A3 (uk)
UA (1) UA76729C2 (uk)
WO (1) WO2002032432A1 (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
EP2148682A1 (en) * 2007-04-23 2010-02-03 Bayer Schering Pharma Aktiengesellschaft Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
US20080268041A1 (en) * 2007-04-23 2008-10-30 Jens Hoffmann Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
JP2010524997A (ja) * 2007-04-23 2010-07-22 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Ｂｒｃａ単独での、又は抗エストロゲン薬を伴った組み合わせ物としての使用のためのプロゲステロン受容体拮抗薬
GB0718167D0 (en) 2007-09-18 2007-10-31 Cancer Rec Tech Ltd Cancer marker and therapeutic target
KR102009007B1 (ko) * 2011-10-04 2019-08-08 인비비스 파마슈티컬스 인코포레이티드 항-프로게스틴 민감성 종양을 확인하고 치료하기 위한 방법 및 시스템

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
UA76729C2 (uk) 2006-09-15
CZ299823B6 (cs) 2008-12-03
CN1469749A (zh) 2004-01-21
IL154976A (en) 2007-05-15
WO2002032432A1 (en) 2002-04-25
JP2004511523A (ja) 2004-04-15
KR100668024B1 (ko) 2007-01-15
EP1326617B1 (en) 2006-08-02
EA010593B1 (ru) 2008-10-30
SK4702003A3 (en) 2004-01-08
HK1062273A1 (en) 2004-10-29
BG107744A (bg) 2004-02-27
CA2423020A1 (en) 2002-04-25
NO20031741L (no) 2003-06-17
CA2423020C (en) 2009-01-20
AU2361902A (en) 2002-04-29
DE60121980D1 (de) 2006-09-14
IL154976A0 (en) 2003-10-31
NO20031741D0 (no) 2003-04-15
MXPA03002955A (es) 2003-08-07
AU2002223619B2 (en) 2006-08-24
NZ538347A (en) 2007-03-30
EP1326617A1 (en) 2003-07-16
EE200300157A (et) 2003-08-15
HRP20030388A2 (en) 2005-04-30
BR0114696A (pt) 2003-11-18
HUP0301433A2 (hu) 2003-10-28
CY1105745T1 (el) 2010-12-22
EP1326617B9 (en) 2006-10-25
EA200300479A1 (ru) 2003-10-30
ES2269492T3 (es) 2007-04-01
SI1326617T1 (sl) 2007-02-28
DE60121980T2 (de) 2007-03-01
DK1326617T3 (da) 2006-12-18
KR20030057540A (ko) 2003-07-04
PL360157A1 (en) 2004-09-06
ATE334683T1 (de) 2006-08-15
CN1209111C (zh) 2005-07-06
HUP0301433A3 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
JP2010077158A (ja) ホルモン−依存性疾病の予防及び処理のための抗黄体ホルモンの使用
AU2002218243A1 (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
PT1326617E (pt) Utilização de 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2-pentafluoroetil)estra-4,9-dien-3-ona para a preparação de um medicamento para o tratamento de cancro da mama, do ovário, do endométrico, mieloma e meningioma
AU2002223619A1 (en) Use of antiprogestins for the induction of apoptosis in a cell
US20040072811A1 (en) Use of antiprogestins for the induction of apoptosis in a cell
KR20060005412A (ko) 호르몬-의존성 질환의 예방 및 치료를 위한 항프로게스틴및 순수한 항에스트로겐을 포함하는 조성물
JP2010524998A (ja) Ｂｒｃａ介在性疾患における使用のための非ステロイド系抗エストロゲンを伴ったプロゲステロン受容体拮抗薬の組み合わせ
TWI306403B (en) Use of antiprogestings for the induction of apoptosis in a cell
ZA200303793B (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases.